ArticleJCI insight2023

Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.

Thuy T Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.